Curcumin in turmeric is responsible for most of the therapeutic effects exhibited by this natural product. Solubility of this dietary compound is very low in water at neutral pH and room temperature, which decreases its bioavailability. This in turn proves to be a major setback in making use of curcumin as a therapeutic agent against many diseases, including cancer.
Introduction
Curcumin (Cur) 
Figure 1 Structure of Curcumin
Cancer refers to a state where cells grow and divide uncontrollably.
Cancer cells follow a number of mutagenic processes, which imparts unlimited proliferation potential and self-sufficiency in growth signals 5 . Instances where combination therapy in cancer treatment causes major side effects to the patients, therapeutic modalities with no or minimal side effects to normal organs have been investigated.
As a potential drug candidate, Cur has been receiving considerable attention because of its putative cancer prevention and anti-cancer activities, which are mediated through multiple signalling pathways [6] [7] [8] .
In spite of the promising anticancer activities, low solubility of Cur in water restricts its use in intravenous administration and is associated with poor absorption in the intestine upon oral administration. Rapid degradation by enzymes residing the intestinal tract causes low oral bioavailability of curcumin 9 . In order to improve the aqueous solubility Stock solutions of Cur (1 mg/mL) and Pluronic® copolymer (10 mg/mL) were prepared in dichloromethane. Required amount of stock solutions was transferred to separate round-bottomed flasks to obtain different drug to polymer ratio. The solvent was evaporated by rotary evaporation at 50 ºC for about 1 hour to obtain drug-containing polymer films. The residual organic solvent remaining in the films was removed by keeping them in the vacuum overnight at room temperature. After that, the films were rehydrated in water and extensively vortexed to prepare drug-encapsulated micelles. Then, the resultant thin film was hydrated with 5 mL water at 40°C, then stirred at 500 rpm for 1 hour to obtain a clear micelle solution, which was filtered through 0.22 μm filter (Millipore) to remove the nonencapsulated drug, followed by lyophilization. Quantitative estimation of the released curcumin in phosphate-buffer saline (PBS) (pH 7.4) was performed using HPLC.
Determination of drug content in micelles
The drug concentration was determined by RP-HPLC method (LC 2010 C HT Shimadzu, Kyoto, Japan). (1) and (2), respectively 20 .
Lyophilized formulation was obtained by freeze-drying Cur encapsulated Pluronic® micelles in a freeze dryer. Drug-loaded micelle samples were rapidly frozen by liquid N2 and attached to the freeze dryer.
In vitro release of Cur from micelles
In vitro Cur release profiles from encapsulated formulation were obtained as follows. Alginate (Alg) 2 wt% solution was prepared.
Alginate/P123/Cur loaded films were produced by casting/solvent evaporation technique in the different drug polymer ratio (shown in table 1 ). The drug loaded films were suspended in glass vessels containing 50 mL of 0.01 M PBS (pH 7.4). At appropriate time intervals aliquots of the solutions were withdrawn and the amount of Cur released were evaluated by UV spectrophotometer at 420 nm.
The release was quantified as follows:
Release kinetics
The Korsmeyer-Peppas model 21 was used to analyze the drug release mechanism from various formulations differing in the drug polymer ratio. This model could be represented as
where Mt/M∞ is the fraction of drug released at time "t" and "k"
represent Korsemeyer-Peppas constant. In the power law model, "n" is the release exponent, indicative of the mechanism of drug release.
The values of "k" and "n" were determined by fitting the release data into the respective equation. Lyophilized formulation was obtained by freeze-drying of Cur encapsulated Pluronic® micelles in a freeze dryer. Drug-loaded micelle samples were rapidly frozen by liquid N2
and attached to the freeze dryer.
In vitro cytotoxic activity
In vitro cytotoxic activity of Cur-P123 micelles were tested using The plates were vigorously shaken before taking measurement of relative colour intensity. The absorbance at 570 nm of each well was measured by a micro plate reader. The results were expressed as mean values ± standard deviation of three measurements.
Analytical characterization and Morphology
Fluorescence spectra were recorded with F-2500 Fluorescence spectrometer (Hitachi, Japan). UV spectroscopic analysis was Microscopy Ltd., Cambridge, United Kingdom). between % cumulative release and time (Fig. 3) . Table 1 show the values of the kinetic exponent (n) and regression coefficient (r 2 ) for all the formulations. It was noted that curcumin is released by the diffusion mechanism 22, 23 . The percentage loading efficiency (% LE) and percentage drug loading (% DL) was calculated from equations (1) and (2) respectively. The best DL% and ER% were 1.39 ± 0.04% and 95.09 ± 2.91% respectively for the composition of 1:8 (w/w) Cur:
Results and Discussions

Drug loading and release studies
P123. This optimized matrix was further used for other characterization studies. Lyophilized Cur-P123 sample was reconstituted with water. It was observed that this sample dissolved to clear solution very quickly and easily, with no noticeable Cur precipitation (Fig 4 (a) ). This suggests that Cur got trapped in the hydrophobic core of P123 micelles (Fig 4   (b) ). 
Release kinetics
The release constants and release exponents (n) were determined by fitting the release data into the respective equations along with regression coefficients (r 2 ). Analysis of regression coefficients for different kinetic models revealed the mechanism of Cur release from Cur-P123 formulation. Tabular values (Table 1 ) of r 2 showed that the power law was best fitted with release kinetic data of Cur.
Thermal analysis
Thermogravimetric analysis (TGA) Fig.5 (a) ).
The Cur entrapment into the inner core of the P123 micelles was confirmed by DSC. As shown in Fig. 5 (b) , the DSC curve indicates an amorphous or disorder crystalline phase of a molecular dispersion or a solid solution state in the polymer matrix.
Fluorescence and UV-visible spectroscopy
Fluorescence spectra of Cur and polymer encapsulated Cur are depicted in Fig. 6 (a) . Ethanolic solution of Cur exhibited an emission peak at 540 nm, while the solution of Cur-P123 show peak at 529
nm. The blue-shifts in the fluorescence are likely due to the intermolecular hydrogen bonding between Cur and hydrophobic core of P123 [25] [26] [27] [28] .
Similarly, UV Visible spectra of ethanolic solution of Cur exhibits an absorption peak at 427 nm, while an aqueous solution of Cur-P123
shows a peak at 408 nm (Fig. 6 (b) ). The blue shifts in the fluorescence and UV Visible spectra are likely due to the formation of intermolecular hydrogen bonding between Cur and P123. 
Fourier Transform-Infrared Spectroscopy analysis
The hydrogen bonding was also evidenced by the IR data (Fig 7 (a) ) of lyophilized Cur-P123 sample and P123. Compared with that of pure Cur, the IR spectrum of Cur-P123 shows a band shift 29 from 3400 to 3417 cm -1 , which is probably due to the hydrogen bonding between OH groups in curcumin and P123. The broad peak between 1200 and 1000 cm -1 is due to the C-O stretching vibration, which is arising from Pluronic® copolymer. Pluronic® polymer was already reported. 21 In DMSO-d6, the aromatic proton signals corresponding to Cur in P123 polymer matrix is seen with lower intensity than compared with the Pluronic® counterpart. This clearly indicates that Cur got entrapped in the hydrophobic PPO core of the co polymer.
Biological studies
Cytotoxicity profile was established using MTT Assay. 
